1,2-dichloroethane increases expression ISO RGD:1332006 6480464 ethylene dichloride results in increased expression of CYP26B1 mRNA CTD PMID:28189721 , PMID:28960355 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CYP26B1 mRNA CTD PMID:17557909 17alpha-ethynylestradiol increases expression ISO RGD:1332006 6480464 Ethinyl Estradiol results in increased expression of CYP26B1 mRNA CTD PMID:31588058 17alpha-ethynylestradiol decreases expression ISO RGD:736189 6480464 Ethinyl Estradiol results in decreased expression of CYP26B1 mRNA CTD PMID:18936297 17beta-estradiol multiple interactions ISO RGD:736189 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP26B1 mRNA, [Estradiol co-treated with TGFB1 protein] results in increased expression of CYP26B1 mRNA CTD PMID:19619570 , PMID:30165855 17beta-estradiol increases expression ISO RGD:736189 6480464 Estradiol results in increased expression of CYP26B1 mRNA CTD PMID:31614463 17beta-estradiol decreases expression ISO RGD:736189 6480464 Estradiol results in decreased expression of CYP26B1 mRNA CTD PMID:19619570 , PMID:32088792 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:736189 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736189 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP26B1 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1332006 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP26B1 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP26B1 mRNA CTD PMID:23238561 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1332006 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP26B1 mRNA CTD PMID:23238561 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP26B1 mRNA CTD PMID:19490992 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736189 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP26B1 mRNA CTD PMID:19619570 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-hydroxypropanoic acid decreases expression ISO RGD:736189 6480464 Lactic Acid results in decreased expression of CYP26B1 mRNA CTD PMID:30851411 4,4'-sulfonyldiphenol increases expression ISO RGD:736189 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CYP26B1 mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol affects methylation ISO RGD:1332006 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of CYP26B1 gene CTD PMID:31683443 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CYP26B1 mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases expression ISO RGD:1332006 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CYP26B1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of CYP26B1 mRNA CTD PMID:14592467 4-hydroxyphenyl retinamide increases expression ISO RGD:1332006 6480464 Fenretinide results in increased expression of CYP26B1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:736189 6480464 Decitabine affects the expression of CYP26B1 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYP26B1 mRNA CTD PMID:24780913 , PMID:25825206 acetamide increases expression EXP 6480464 acetamide results in increased expression of CYP26B1 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CYP26B1 mRNA CTD PMID:28959563 all-trans-retinoic acid decreases abundance ISO RGD:736189 6480464 CYP26B1 gene SNP results in decreased abundance of Tretinoin CTD PMID:29379198 all-trans-retinoic acid increases expression ISO RGD:736189 6480464 Tretinoin results in increased expression of CYP26B1 mRNA CTD PMID:17431108 more ... all-trans-retinoic acid increases degradation EXP 6480464 CYP26B1 protein results in increased degradation of Tretinoin CTD PMID:21138835 , PMID:27899881 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CYP26B1 mRNA CTD PMID:14592467 more ... all-trans-retinoic acid multiple interactions EXP 6480464 [R 115866 results in decreased activity of CYP26B1 protein] which results in increased abundance of Tretinoin, Lipopolysaccharides inhibits the reaction [Tretinoin results in increased expression of CYP26B1 mRNA] CTD PMID:17185629 , PMID:17510468 all-trans-retinoic acid increases expression ISO RGD:1332006 6480464 Tretinoin results in increased expression of CYP26B1 mRNA CTD PMID:16688765 all-trans-retinoic acid multiple interactions ISO RGD:736189 6480464 [R 115866 results in decreased activity of CYP26B1 protein] which results in increased activity of Tretinoin more ... CTD PMID:14532297 more ... all-trans-retinoic acid increases metabolic processing ISO RGD:736189 6480464 CYP26B1 protein results in increased metabolism of Tretinoin, CYP26B1 results in increased metabolism of Tretinoin CTD PMID:14532297 , PMID:17486130 all-trans-retinoic acid decreases activity ISO RGD:736189 6480464 CYP26B1 protein results in decreased activity of Tretinoin CTD PMID:20606468 all-trans-retinoic acid affects degradation ISO RGD:736189 6480464 CYP26B1 protein affects the degradation of Tretinoin CTD PMID:16574820 all-trans-retinol multiple interactions EXP 6480464 [R 115866 co-treated with Vitamin A] results in increased expression of CYP26B1 mRNA CTD PMID:17510468 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP26B1 mRNA CTD PMID:16483693 arecoline decreases expression ISO RGD:736189 6480464 Arecoline results in decreased expression of CYP26B1 mRNA CTD PMID:17682004 aristolochic acid A increases expression ISO RGD:736189 6480464 aristolochic acid I results in increased expression of CYP26B1 mRNA CTD PMID:33212167 arotinoid acid multiple interactions ISO RGD:736189 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane increases expression ISO RGD:1332006 6480464 Arsenic results in increased expression of CYP26B1 mRNA CTD PMID:19654921 arsane affects methylation ISO RGD:736189 6480464 Arsenic affects the methylation of CYP26B1 gene CTD PMID:25304211 arsenic atom increases expression ISO RGD:1332006 6480464 Arsenic results in increased expression of CYP26B1 mRNA CTD PMID:19654921 arsenic atom affects methylation ISO RGD:736189 6480464 Arsenic affects the methylation of CYP26B1 gene CTD PMID:25304211 arsenite(3-) multiple interactions ISO RGD:736189 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CYP26B1 mRNA] CTD PMID:32406909 azoxystrobin decreases expression ISO RGD:736189 6480464 azoxystrobin results in decreased expression of CYP26B1 mRNA CTD PMID:33512557 benzo[a]pyrene multiple interactions ISO RGD:1332006 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to CYP26B1 promoter] CTD PMID:19654925 benzo[a]pyrene increases expression ISO RGD:736189 6480464 Benzo(a)pyrene results in increased expression of CYP26B1 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1332006 6480464 Benzo(a)pyrene results in increased methylation of CYP26B1 exon, Benzo(a)pyrene results in increased methylation of CYP26B1 intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1332006 6480464 Benzo(a)pyrene results in increased expression of CYP26B1 mRNA CTD PMID:27195522 benzo[a]pyrene decreases expression ISO RGD:1332006 6480464 Benzo(a)pyrene results in decreased expression of CYP26B1 mRNA CTD PMID:21569818 benzo[b]fluoranthene decreases expression ISO RGD:1332006 6480464 benzo(b)fluoranthene results in decreased expression of CYP26B1 mRNA CTD PMID:26377693 bexarotene increases expression ISO RGD:1332006 6480464 bexarotene results in increased expression of CYP26B1 mRNA CTD PMID:17849452 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP26B1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CYP26B1 mRNA CTD PMID:36041667 bisphenol A increases expression ISO RGD:1332006 6480464 bisphenol A results in increased expression of CYP26B1 mRNA CTD PMID:32365465 , PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP26B1 mRNA CTD PMID:32145629 bisphenol F increases expression ISO RGD:1332006 6480464 bisphenol F results in increased expression of CYP26B1 mRNA CTD PMID:30951980 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CYP26B1 mRNA CTD PMID:36041667 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of CYP26B1 mRNA CTD PMID:32479839 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of CYP26B1 mRNA CTD PMID:19167457 cadmium atom decreases expression ISO RGD:1332006 6480464 Cadmium results in decreased expression of CYP26B1 mRNA CTD PMID:19556237 calcitriol increases expression ISO RGD:736189 6480464 Calcitriol results in increased expression of CYP26B1 mRNA CTD PMID:16002434 , PMID:26485663 camptothecin decreases response to substance ISO RGD:736189 6480464 CYP26B1 mRNA results in decreased susceptibility to Camptothecin CTD PMID:25269479 carbon nanotube increases expression ISO RGD:1332006 6480464 Nanotubes more ... CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:736189 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP26B1 gene] CTD PMID:28238834 CHIR 99021 multiple interactions ISO RGD:736189 6480464 [4-(2-(5 more ... CTD PMID:34480604 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of CYP26B1 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1332006 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CYP26B1 gene CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CYP26B1 mRNA CTD PMID:22023808 cisplatin decreases expression ISO RGD:736189 6480464 Cisplatin results in decreased expression of CYP26B1 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:736189 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CYP26B1 mRNA CTD PMID:27392435 cisplatin affects expression ISO RGD:736189 6480464 Cisplatin affects the expression of CYP26B1 mRNA CTD PMID:23300844 cocaine decreases response to substance EXP 6480464 CYP26B1 protein results in decreased susceptibility to Cocaine CTD PMID:27899881 copper(II) sulfate increases expression ISO RGD:736189 6480464 Copper Sulfate results in increased expression of CYP26B1 mRNA CTD PMID:19549813 cortisol multiple interactions ISO RGD:736189 6480464 [4-(2-(5 more ... CTD PMID:34480604 cyhalothrin decreases expression EXP 6480464 cyhalothrin results in decreased expression of CYP26B1 mRNA CTD PMID:29727961 cypermethrin multiple interactions ISO RGD:1332006 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of CYP26B1 mRNA] CTD PMID:31659573 cypermethrin decreases expression ISO RGD:1332006 6480464 cypermethrin results in decreased expression of CYP26B1 mRNA CTD PMID:31659573 cyproconazole increases expression ISO RGD:1332006 6480464 cyproconazole results in increased expression of CYP26B1 mRNA CTD PMID:22045034 deguelin decreases expression ISO RGD:736189 6480464 deguelin results in decreased expression of CYP26B1 mRNA CTD PMID:33512557 dextran sulfate decreases expression ISO RGD:1332006 6480464 Dextran Sulfate results in decreased expression of CYP26B1 mRNA CTD PMID:35093514 dibenz[a,h]anthracene decreases expression ISO RGD:1332006 6480464 1 more ... CTD PMID:26377693 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of CYP26B1 mRNA CTD PMID:21161181 diethylstilbestrol increases expression ISO RGD:736189 6480464 Diethylstilbestrol results in increased expression of CYP26B1 mRNA CTD PMID:32088792 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CYP26B1 mRNA CTD PMID:33729688 diquat increases expression ISO RGD:1332006 6480464 Diquat results in increased expression of CYP26B1 mRNA CTD PMID:36851058 disodium selenite multiple interactions ISO RGD:1332006 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of CYP26B1 mRNA] CTD PMID:31659573 diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of CYP26B1 mRNA CTD PMID:24172598 doxorubicin decreases expression ISO RGD:736189 6480464 Doxorubicin results in decreased expression of CYP26B1 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CYP26B1 mRNA CTD PMID:29391264 fipronil increases expression ISO RGD:736189 6480464 fipronil results in increased expression of CYP26B1 mRNA CTD PMID:27091632 fipronil multiple interactions ISO RGD:736189 6480464 [fipronil co-treated with DEET] results in increased expression of CYP26B1 mRNA CTD PMID:27091632 fluconazole increases expression ISO RGD:1332006 6480464 Fluconazole results in increased expression of CYP26B1 mRNA CTD PMID:19429397 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of CYP26B1 mRNA CTD PMID:17033635 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of CYP26B1 mRNA CTD PMID:28263823 folic acid multiple interactions ISO RGD:1332006 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CYP26B1 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:1332006 6480464 Folic Acid results in decreased expression of CYP26B1 mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of CYP26B1 mRNA CTD PMID:25539665 , PMID:27387713 furan decreases methylation EXP 6480464 furan results in decreased methylation of CYP26B1 gene CTD PMID:27387713 genistein increases expression ISO RGD:1332006 6480464 Genistein results in increased expression of CYP26B1 mRNA CTD PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CYP26B1 mRNA CTD PMID:33387578 hexaconazole increases expression ISO RGD:1332006 6480464 hexaconazole results in increased expression of CYP26B1 mRNA CTD PMID:22045034 hexadecanoic acid multiple interactions ISO RGD:736189 6480464 [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26B1 mRNA CTD PMID:30547786 isoprenaline decreases expression ISO RGD:1332006 6480464 Isoproterenol results in decreased expression of CYP26B1 mRNA CTD PMID:20003209 isotretinoin multiple interactions ISO RGD:736189 6480464 R116010 promotes the reaction [Isotretinoin results in increased expression of CYP26B1 mRNA] CTD PMID:17486130 isotretinoin increases expression ISO RGD:736189 6480464 Isotretinoin results in increased expression of CYP26B1 mRNA CTD PMID:17486130 , PMID:18769122 ketoconazole multiple interactions ISO RGD:736189 6480464 Ketoconazole inhibits the reaction [CYP26B1 protein results in increased metabolism of Tretinoin], Ketoconazole inhibits the reaction [CYP26B1 results in increased metabolism of Tretinoin] CTD PMID:14532297 , PMID:21906690 ketoconazole decreases activity ISO RGD:736189 6480464 Ketoconazole results in decreased activity of CYP26B1 CTD PMID:14532297 kojic acid increases expression ISO RGD:736189 6480464 kojic acid results in increased expression of CYP26B1 mRNA CTD PMID:16595896 L-ascorbic acid multiple interactions ISO RGD:736189 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP26B1 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:736189 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP26B1 mRNA CTD PMID:34480604 L-methionine multiple interactions ISO RGD:1332006 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CYP26B1 gene CTD PMID:20938992 leflunomide decreases expression ISO RGD:1332006 6480464 leflunomide results in decreased expression of CYP26B1 mRNA CTD PMID:19751817 lipopolysaccharide multiple interactions EXP 6480464 Lipopolysaccharides inhibits the reaction [Tretinoin results in increased expression of CYP26B1 mRNA] CTD PMID:17185629 lipopolysaccharide increases expression ISO RGD:736189 6480464 Lipopolysaccharides results in increased expression of CYP26B1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:736189 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CYP26B1 mRNA] CTD PMID:35811015 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of CYP26B1 mRNA CTD PMID:26745496 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of CYP26B1 mRNA CTD PMID:26745496 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of CYP26B1 mRNA CTD PMID:26745496 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of CYP26B1 mRNA CTD PMID:23303685 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of CYP26B1 gene CTD PMID:23303685 N,N-diethyl-m-toluamide multiple interactions ISO RGD:736189 6480464 [fipronil co-treated with DEET] results in increased expression of CYP26B1 mRNA CTD PMID:27091632 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of CYP26B1 mRNA CTD PMID:17203325 , PMID:26720608 oleic acid multiple interactions ISO RGD:736189 6480464 [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26B1 mRNA CTD PMID:30547786 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of CYP26B1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CYP26B1 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1332006 6480464 Acetaminophen affects the expression of CYP26B1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP26B1 mRNA CTD PMID:33387578 paraquat increases expression ISO RGD:1332006 6480464 Paraquat results in increased expression of CYP26B1 mRNA CTD PMID:21371552 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1332006 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CYP26B1 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP26B1 mRNA CTD PMID:28511854 phenobarbital affects expression ISO RGD:1332006 6480464 Phenobarbital affects the expression of CYP26B1 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:736189 6480464 Phenobarbital results in increased expression of CYP26B1 mRNA CTD PMID:22258563 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of CYP26B1 mRNA CTD PMID:18158353 picoxystrobin decreases expression ISO RGD:736189 6480464 picoxystrobin results in decreased expression of CYP26B1 mRNA CTD PMID:33512557 quercitrin increases expression ISO RGD:736189 6480464 quercitrin results in increased expression of CYP26B1 mRNA CTD PMID:25193878 quinalphos decreases expression ISO RGD:1332006 6480464 quinalphos results in decreased expression of CYP26B1 mRNA CTD PMID:24581381 quinalphos multiple interactions ISO RGD:1332006 6480464 Plant Extracts inhibits the reaction [quinalphos results in decreased expression of CYP26B1 mRNA] CTD PMID:24581381 quinolines multiple interactions ISO RGD:736189 6480464 Quinolines analog inhibits the reaction [Tretinoin results in increased expression of CYP26B1 mRNA] CTD PMID:35483669 rac-lactic acid decreases expression ISO RGD:736189 6480464 Lactic Acid results in decreased expression of CYP26B1 mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:736189 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of CYP26B1 mRNA CTD PMID:19059307 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP26B1 mRNA CTD PMID:25905778 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:736189 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CYP26B1 mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:736189 6480464 [LDN 193189 co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of CYP26B1 mRNA CTD PMID:34480604 silicon dioxide decreases expression ISO RGD:736189 6480464 Silicon Dioxide analog results in decreased expression of CYP26B1 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:1332006 6480464 Silicon Dioxide results in decreased expression of CYP26B1 mRNA CTD PMID:29341224 silicon dioxide increases expression ISO RGD:736189 6480464 Silicon Dioxide analog results in increased expression of CYP26B1 mRNA CTD PMID:23806026 sodium arsenite decreases expression ISO RGD:736189 6480464 sodium arsenite results in decreased expression of CYP26B1 mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO RGD:1332006 6480464 sodium arsenite results in decreased expression of CYP26B1 mRNA CTD PMID:36209798 Soman increases expression EXP 6480464 Soman results in increased expression of CYP26B1 mRNA CTD PMID:19281266 sotorasib multiple interactions ISO RGD:736189 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CYP26B1 mRNA CTD PMID:36139627 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP26B1 mRNA CTD PMID:25905778 sulforaphane multiple interactions ISO RGD:1332006 6480464 [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CYP26B1 mRNA CTD PMID:30529165 sunitinib decreases expression ISO RGD:736189 6480464 Sunitinib results in decreased expression of CYP26B1 mRNA CTD PMID:31533062 tamoxifen decreases expression ISO RGD:1332006 6480464 Tamoxifen results in decreased expression of CYP26B1 mRNA CTD PMID:25123088 tamoxifen multiple interactions ISO RGD:736189 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of CYP26B1 mRNA CTD PMID:19059307 titanium dioxide decreases expression ISO RGD:1332006 6480464 titanium dioxide results in decreased expression of CYP26B1 mRNA CTD PMID:23557971 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CYP26B1 mRNA CTD PMID:30012374 toluene affects expression EXP 6480464 Toluene affects the expression of CYP26B1 mRNA CTD PMID:18653662 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CYP26B1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of CYP26B1 mRNA CTD PMID:25729387 trametinib multiple interactions ISO RGD:736189 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CYP26B1 mRNA CTD PMID:36139627 trichloroethene decreases expression ISO RGD:1332006 6480464 Trichloroethylene results in decreased expression of CYP26B1 mRNA CTD PMID:25549359 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CYP26B1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:736189 6480464 trichostatin A results in increased expression of CYP26B1 mRNA CTD PMID:24935251 trimellitic anhydride decreases expression ISO RGD:1332006 6480464 trimellitic anhydride results in decreased expression of CYP26B1 mRNA CTD PMID:19042947 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CYP26B1 mRNA CTD PMID:30589522 valproic acid affects expression ISO RGD:1332006 6480464 Valproic Acid affects the expression of CYP26B1 mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:736189 6480464 Valproic Acid results in increased expression of CYP26B1 mRNA CTD PMID:24383497 , PMID:28001369 valproic acid decreases expression ISO RGD:1332006 6480464 Valproic Acid results in decreased expression of CYP26B1 mRNA CTD PMID:22045034 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYP26B1 mRNA CTD PMID:20566332 vinyl carbamate decreases expression ISO RGD:1332006 6480464 vinyl carbamate results in decreased expression of CYP26B1 mRNA CTD PMID:17849452 XAV939 multiple interactions ISO RGD:736189 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP26B1 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP26B1 mRNA CTD PMID:34480604
